Susumu Muto

This inventor holds 13 USPTO granted patents and 7 published patent applications and 3 EPO patents. Top assignees: Institute of Medicinal Molecular Design, Inc., Shionogi Company Limited. Active years: 2008-2014.

USPTO Granted Patents = 13 (Patent Applications = 7)

% Patents Active = 7.7

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 108(Granted Patents)

Location History:

Machida, JP (2011)
Bunkyo-ku, JP (2012)
Tokyo, JP (2008 - 2014)

Company Filing History:

13 out of 21

Institute of Medicinal Molecular Design, Inc.

patents

2 out of 1,001

Shionogi Company Limited

patents

where one patent can have more than one assignee

Years Active: 2008-2014

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8633245 - PAI-1 inhibitor (2014-01-21),

2. 8263657 - Inhibitors against the production and release of inflammatory cytokines (2012-09-11),

3. 8097759 - Inflammatory cytokine release inhibitor (2012-01-17),

4. 8097610 - Derivative having PPAR agonistic activity (2012-01-17),

5. 8044236 - Carboxilic acid derivatives (2011-10-25),

6. 7998992 - Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1 (2011-08-16),

7. 7884234 - N-phenyloxamide derivatives (2011-02-08),

8. 7700655 - Antiallergic agents (2010-04-20),

9. 7671058 - N-(3,4-disubstituted phenyl) salicylamide derivatives (2010-03-02),

10. 7626042 - O-substituted hydroxyaryl derivatives (2009-12-01),

11. 7598418 - Amide derivatives (2009-10-06),

12. 7547716 - Sulfonamide derivatives (2009-06-16),

13. 7411076 - Coumarin derivative (2008-08-12),

Title: The Innovations of Susumu Muto

Introduction

Susumu Muto, an accomplished inventor based in Tokyo, Japan, holds an impressive portfolio of 13 patents. His groundbreaking work primarily focuses on the development of compounds with significant therapeutic applications, particularly in the fields of molecular medicine and inflammation management.

Latest Patents

Among his latest innovations is a PAI-1 inhibitor, which is represented by a complex chemical formula. This compound exhibits PAI-1 inhibition activity, with various substituents that enhance its efficacy. Additionally, Muto has developed inhibitors against the production and release of inflammatory cytokines. This medicament demonstrates inhibitory activity against NF-κB activation, employing unique molecular configurations to deliver therapeutic benefits.

Career Highlights

Muto's career features impactful contributions while working at prominent organizations such as the Institute of Medicinal Molecular Design and Shionogi & Company Limited. His focus on medicinal chemistry and drug development has been instrumental in advancing pharmaceutical solutions.

Collaborations

Throughout his career, Susumu Muto has collaborated with distinguished professionals such as Akiko Itai and Takeshi Yanase. These partnerships have fostered an environment of innovation, allowing for the exploration of novel therapeutic strategies.

Conclusion

Susumu Muto's contributions to science through his patents are invaluable. His relentless pursuit of innovation continues to enhance the understanding and treatment of various medical conditions, showcasing the essential role of inventors in advancing healthcare technologies.